Novel anti-PD-L1/IL-15 bifunctional immunotherapeutics potentiates antitumor immunity

被引：0
|
作者：
Wu, Yan
Zhong, Zhaojing
Martomo, Stella
Lu, Dan
Zhang, Haifan
Polonskaya, Zhanna
Luna, Xenia
Zhang, Zhikai
Wang, Zhun
Liu, Leo
Patel, Jeegar
Tonra, James
Li, Henry
Witte, Larry
Waksal, Sam
Zhu, Zhenping
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-4997
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4997
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Targeting IL-33 reprograms the tumor microenvironment and potentiates antitumor response to anti-PD-L1 immunotherapy (vol 12, e009236, 2024)
    Nan, Y.
    Bai, Y.
    Hu, X.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (11)
  • [22] Anti-PD-L1/IL-15 fusion protein generates robust adaptive immune gene signatures in tumours leading to tumour inhibition and memory responses
    Martomo, S.
    Feng, X-J.
    Lu, D.
    Polonskaya, Z.
    Luna, X.
    Poyurovsky, M. V.
    McCracken, K.
    Miyara, F.
    Li, L.
    Aggarwal, S.
    Patel, J.
    ANNALS OF ONCOLOGY, 2019, 30 : 499 - +
  • [23] Hair RepigmentationWith Anti-PD-1 and Anti-PD-L1 Immunotherapy: A Novel Hypothesis
    Sebaratnam, Deshan Frank
    Rodriguez Bandera, Ana Isabel
    Lowe, Patricia Margaret
    JAMA DERMATOLOGY, 2018, 154 (01) : 112 - 113
  • [24] Development of bifunctional anti-PD-L1 antibody MMAE conjugate with cytotoxicity and immunostimulation
    Xiao, Dian
    Luo, Longlong
    Li, Jiaguo
    Wang, Zhihong
    Liu, Lianqi
    Xie, Fei
    Feng, Jiannan
    Zhou, Xinbo
    BIOORGANIC CHEMISTRY, 2021, 116
  • [25] Comparative analysis of pharmacokinetics and antitumor effect between anti-PD-1 and anti-PD-L1 in mice models
    Hatakeyama, Hiroto
    Kurino, Taiki
    Suzuki, Hiroyuki
    Terui, Ayu
    Uehara, Tomoya
    Arano, Yasushi
    Hisaka, Akihiro
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [26] Inhibition of MBTPS1 enhances antitumor immunity and potentiates anti-PD-1 immunotherapy
    Yi-Yu Wang
    Jin-Fei Lin
    Wen-Wei Wu
    Zhe Fu
    Fen Cao
    Yan-Xing Chen
    Hai-Yu Mo
    Hui Sheng
    Ze-Xian Liu
    Zhao-Lei Zeng
    Xin-Yuan Guan
    Huai-Qiang Ju
    Kun Liao
    Rui-Hua Xu
    Nature Communications, 16 (1)
  • [27] Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1
    Jiming Chen
    Jie Yang
    Wenhui Wang
    Danfeng Guo
    Chengyan Zhang
    Shibo Wang
    Xinliang Lu
    Xiaofang Huang
    Pingli Wang
    Gensheng Zhang
    Jing Zhang
    Jianli Wang
    Zhijian Cai
    Cellular & Molecular Immunology, 2022, 19 : 1290 - 1301
  • [28] A Novel Anti-PD-L1 Vaccine for Cancer Immunotherapy and Immunoprevention
    Chen, Jie
    Liu, Hui
    Jehng, Tiffany
    Li, Yanqing
    Chen, Zhoushi
    Lee, Kuan-Der
    Shen, Hsieh-Tsung
    Jones, Lindsey
    Huang, Xue F.
    Chen, Si-Yi
    CANCERS, 2019, 11 (12)
  • [29] Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1
    Chen, Jiming
    Yang, Jie
    Wang, Wenhui
    Guo, Danfeng
    Zhang, Chengyan
    Wang, Shibo
    Lu, Xinliang
    Huang, Xiaofang
    Wang, Pingli
    Zhang, Gensheng
    Zhang, Jing
    Wang, Jianli
    Cai, Zhijian
    CELLULAR & MOLECULAR IMMUNOLOGY, 2022, 19 (11) : 1290 - 1301
  • [30] Optimization strategies for expression of a novel bifunctional anti-PD-L1/TGFBR2-ECD fusion protein
    Gao, Zhang-zhao
    Li, Cui
    Chen, Gang
    Yuan, Jun-jie
    Zhou, Ya-qiong
    Jiao, Jing-yu
    Nie, Lei
    Qi, Jian
    Yang, Yong
    Chen, Shu-qing
    Wang, Hai-bin
    PROTEIN EXPRESSION AND PURIFICATION, 2022, 189
12345